GBMA Welcomes Australian Budget Co-Payment Commitment
Government Has Committed To Cutting AUD12.50 From PBS Co-Payment
The Australian government has committed to cutting co-payments for medicines listed on its pharmaceutical benefits scheme by 30%, a move which has been praised by the country’s Generic and Biosimilar Medicines Association.
You may also be interested in...
Australia’s health department has issued guidance giving more details of the requirement to hold minimum levels of stocks of specified medicines from mid-2023.
Australia’s branded and generic drug industry associations have jointly raised concerns about the impact ongoing shortages could have on the country’s supply of medicines.
As Australia’s GBMA launches its latest Biosimilars Awareness Week – the last under a five-year education grant – the association says it is looking forward to “the dawn of a new era” as it begins working with the newly-elected Labor government.